Unraveling the protein kinase C/NDRG1 signaling network in breast cancer

C Saponaro1, M Damato2, E Stanca2

  • 1Pathology Department, IRCCS Istituto Tumori "Giovanni Paolo II", 70124, Bari, Italy.

Cell & Bioscience
|December 30, 2024
PubMed

Insights

N-myc downstream-regulated gene 1 (NDRG1) is a poor prognostic marker in breast cancer (BC). Protein kinase C (PKC) activation enhances NDRG1 expression, driving BC cell invasion via the ROCK1/cofilin pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • N-myc downstream-regulated gene 1 (NDRG1) is implicated in cellular processes and linked to poor prognosis in various cancers.
  • Overexpression of NDRG1 correlates with adverse outcomes in breast cancer (BC).

Purpose of the Study:

  • To investigate NDRG1 as a prognostic marker in breast cancer.
  • To elucidate the regulatory mechanisms of NDRG1 expression and its role in BC progression.

Main Methods:

  • Analysis of TCGA dataset for NDRG1 and PRKCA expression correlation.
  • Induction of NDRG1 expression under acute stress conditions activating protein kinase C (PKC).
  • CRISPR-based inhibition of NDRG1 in a BC cell line to assess its role in invasion.

Main Results:

  • NDRG1 is an independent prognostic marker of poor outcome in breast cancer.
  • A positive correlation between NDRG1 and PRKCA suggests PKC regulates NDRG1 expression.
  • PKC activation enhances NDRG1 expression specifically, not other NDRG family members.
  • NDRG1 drives BC cell invasion through the ROCK1/cofilin pathway, impacting stress fibers and extracellular matrix.

Conclusions:

  • NDRG1 serves as a potential biomarker for poor prognosis in breast cancer.
  • A novel PKC-mediated pathway regulates NDRG1 expression.
  • Targeting NDRG1 may offer new therapeutic strategies for breast cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
75.7K